BiotechTube
Home/Pipeline/Strategic Market Re-entry (Post-2026)

Strategic Market Re-entry (Post-2026)

Not Specified

Business DevelopmentActive

Key Facts

Indication
Not Specified
Phase
Business Development
Status
Active
Company
Manx Healthcare

About Manx Healthcare

Manx Healthcare is an established, private commercial-stage company in the generic and OTC pharmaceutical sector. It leverages a family-owned, independent structure to offer a broad portfolio of affordable medicines, focusing on reliable supply and customer relationships. Recent strategic moves include a portfolio sale and planned market expansion, positioning the company for new opportunities post-2026 while maintaining its core operations in the UK and beyond.

View full company profile

Therapeutic Areas

Pain ReliefTravel HealthDentalInfectionGut HealthBaby Care

Other Not Specified Drugs

DrugCompanyPhase
FL116Forlong BiotechnologyNot specified
FL117Forlong BiotechnologyNot specified
FL118Forlong BiotechnologyNot specified
FL301Forlong BiotechnologyNot specified
JSKN016AlphaMab OncologyPhase 1
JSKN033AlphaMab OncologyPhase 1
JSKN022AlphaMab OncologyPhase 1
JSKN027AlphaMab OncologyPhase 1
KN019AlphaMab OncologyPhase 1
New TCM FormulationsChina SXT PharmaceuticalsResearch / Pre-clinical
Long-acting LeronlimabCytoDynPreclinical
SR2162SIMR (Australia) BiotechIND Approved